Position in GLUE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,780,503
+$2,182,541 QoQ
Shares Held
652,087
-21.1% QoQ
Ownership
0.764%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 193 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. GLUE ranks #91 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in GLUE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,780,503 | 652,087 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $13,597,962 | 826,624 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $10,929,491 | 697,034 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,488,466 | 740,684 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,433,998 | 761,419 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,731,678 | 373,207 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,616,129 | 376,964 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,900,436 | 358,573 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,100,292 | 294,196 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,047,700 | 290,454 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,609,877 | 284,934 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,126,576 | 443,962 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,935,148 | 428,489 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,951,604 | 250,527 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,941,393 | 255,111 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,027,384 | 248,150 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,163,806 | 223,765 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,080,726 | 219,738 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,208,729 | 108,165 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,317,052 | 103,997 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||